News + Filings Transactions
|
Williams Kristen Marie
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/14/2023 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 11k | $0.00 | $0 | | 06/14/2023 |
06/14/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 6.5k | $37.03 | $239.5k | | 06/14/2023 |
06/14/2023 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 27.5k | $38.74 | $1.1M | | 06/14/2023 |
06/07/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 1.4k | $37.87 | $51.4k | | 06/06/2023 |
06/06/2023 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 1.3k | $38.99 | $50.7k | | 06/06/2023 |
06/08/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 9.9k | $0.00 | $0 | | 06/06/2022 |
06/08/2022 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 24.8k | $59.39 | $1.5M | | 06/06/2022 |
06/07/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 4.6k | $59.51 | $276.7k | | 06/06/2022 |
06/06/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 4k | $61.37 | $243.6k | | 06/06/2022 |
03/21/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 7.3k | $72.67 | $527.1k | | 03/21/2022 |
03/21/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 3k | $38.35 | $113.2k | | 03/21/2022 |
03/21/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2.1k | $43.54 | $92k | | 03/21/2022 |
03/21/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2.2k | $47.65 | $104.3k | | 03/21/2022 |
02/25/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 50 | $65.00 | $3.2k | | 02/16/2022 |
02/25/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 2k | $67.07 | $134.1k | | 02/16/2022 |
02/25/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2k | $38.35 | $78.6k | | 02/16/2022 |
02/16/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 10 | $38.35 | $383.5 | | 02/16/2022 |
02/16/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 10 | $65.00 | $650 | | 02/16/2022 |
02/04/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 1000 | $65.18 | $65.2k | | 02/04/2022 |
02/04/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 1000 | $38.35 | $38.4k | | 02/04/2022 |
01/21/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 200 | $65.41 | $13.1k | | 01/21/2022 |
01/21/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 200 | $38.35 | $7.7k | | 01/21/2022 |
01/19/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 2.2k | $65.51 | $144.1k | | 01/18/2022 |
01/19/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2.2k | $38.35 | $84.3k | | 01/18/2022 |
01/18/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 1.4k | $44.20 | $60.8k | | 01/18/2022 |
01/18/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2.6k | $38.35 | $99.7k | | 01/18/2022 |
01/18/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 6.3k | $43.54 | $276k | | 01/18/2022 |
01/18/2022 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 13.1k | $47.65 | $625.5k | | 01/18/2022 |
01/18/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 23k | $65.24 | $1.5M | | 01/18/2022 |
01/18/2022 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 400 | $66.14 | $26.5k | | 01/18/2022 |
06/10/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 4.8k | $59.43 | $287.8k | | 06/09/2021 |
06/10/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 847 | $60.57 | $51.3k | | 06/09/2021 |
06/09/2021 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 17.5k | $60.96 | $1.1M | | 06/09/2021 |
06/09/2021 | Pacira BioSciences, Inc. | PCRX | Grant | Common Stock | 7k | $0.00 | $0 | | 06/09/2021 |
06/04/2021 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 3.9k | $61.04 | $239.9k | | 06/04/2021 |
|
|